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Insulin resistance is a manifestation of both diabetes mellitus 
and obesity. Insulin signaling and its impairment in obesity and 
type 2 diabetes continue to excite researchers. Permanent increase 
in acute-phase serum amyloid A (A-SAA) level has been 
observed and correlated to both obesity and insulin resistance in 
humans. In this study, we explored the mechanism of recombinant 
serum amyloid A (Rh-SAA) mediating insulin resistance and JNK 
activation of 3T3-L1 adipocytes. We could observe the effect of 
Rh-SAA on insulin sensitivity of 3T3-LI adipocytes under the 
intervention of JNK inhibitors. We selected three experimental 
groups viz. (i) NC Group: Adipocytes without Rh-SAA 
intervention,;(ii) Rh-SAA Group: A dipocytes with 20μg/mL Rh-
SAA intervention; and (iii) JNK Inhibitor Group: Adipocytes 
pretreated with 50 μmol/L JNK inhibitor SP600125 12 h before 
20 μg/mL Rh-SAA intervention. All the three groups were 
incubated for 48 h, the glucose transport rate of the adipocytes 
was measured by3H-2-DG, and the level of JNK activation was 
examined using Western blotting. Compared with the NC group, 
glucose uptake in the adipocytes treated with 20μg/mL Rh-SAA 
for 48 h decreased by 26% (P <0.01). The glucose uptake 
increased by 15% (P <0.05) in the JNK Inhibitor group. Western 
blotting showed that the expression levels of p-JNK in the NC 
group and Rh-SAA group and JNK inhibitor group were 100, 166 
and 107%, respectively. Compared with NC group, the 
phosphorylation of JNK increased by 66% (P <0.01), but JNK 
inhibitor group showed no significant difference between Rh-
SAA group (P <0.01) and NC group (P <0.05). Results suggested 
that intervening activity of JNK is expected to be an effective 
treatment for insulin resistance related diseases. 
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Insulin resistance refers to the decrease in the 
efficiency of insulin in promoting glucose uptake and 
its utilization for various processes, and the 
compensatory secretion of excessive insulin by the 
body produces hyperinsulinemia to maintain the 
stability of blood glucose1,2. Insulin resistance 
predisposes an individual to metabolic syndrome and 
type 2 diabetes3. Plasma insulin concentrations were 
measured by radioimmunoassay principle and it was 
found that patients with lower plasma insulin levels 
had higher insulin sensitivity, while people with 
higher plasma insulin are insensitive to insulin4. In 
recent years, Jun N-terminal kinase (JNK) has 
emerged as an important metabolic modulator which 
plays a key role in obesity-related insulin resistance 
(IR)5. Reduced insulin sensitivity and the biological 
efficacy after binding to its specific receptors should 
be lower than the standard level in IR. The clinical 
symptoms are abnormal glucose uptake in peripheral 
tissues and increased hepatic glucose output6. IR in 
adipose or adipose peripheral tissue refers to its 
reduced ability to utilize glucose under the action of a 
certain concentration of insulin, resulting in low 
glucose tolerance5,6. Adipose tissue, an active 
endocrine organ produces adipokines, including 
leptin, adiponectin, endorphins, tumor necrosis 
factor-α (TNF-α), interleukin-6 (IL-6), resistin, endofat, 
etc.7 All the changes in adipokines affect the onset of 
biological effects of insulin, including adipose insulin 
sensitivity and regulation of skeletal muscle and liver 
insulin sensitivity through the blood6,7. 
The IR refers to a state in which normal doses of 
insulin produce subnormal biological effects, mainly 
manifested as resistance of insulin-sensitive cells to 
insulin-mediated glucose uptake and disposal as well 
as to lipid and egg white matter metabolism3,8. It is a 
common risk factor for a variety of diseases, such as 
diabetes and cardiovascular disease, often causing the 
occurrence of a variety of metabolic diseases9. The 
etiology of IR and its generation mechanism have 
been widely studied, mechanism of IR produced in 
different physiological and pathological conditions is 
not the same, and shows obvious heterogeneity of 
IR10. It causes defects in the structure and function of 
various signaling molecules in the pre-receptor, 
receptor and post-receptor of insulin target tissues as 
well as the abnormalities in the hormones regulating 
insulin action11. In the past few years, the mechanism 
of IR has been mainly focused mainly on insulin 
intracellular signaling pathway after insulin sensitive 
classical target organs such as liver, skeletal muscle 
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and adipocyte receptors. The IR in such target  
organs is mainly a risk factor interfering with the IR 
S-1/PI3K/Akt/GLUT-4 signaling pathway, which 
attenuates insulin-mediated glucose uptake and 
subsequent disposal in these target organs and 
increases hepatic glucose production and output12. 
 
Serum amyloid A (SAA) is an acute-phase protein 
that has been recently correlated with obesity and 
insulin resistance13. Until recently, it was thought that 
the expression and release of SAA occurs 
predominantly in the liver, however, it has been found 
that human adipose tissue is a major SAA expression 
site during the non-acute-phase reactions14. Previous 
reports have shown that the insulin resistance in 
adipocytes could be induced by recombinant human 
serum amyloid A (Rh-SAA)8,15. However, the 
mechanism of Rh-SAA mediated insulin resistance in 
adipocytes has not been fully explained. Therefore, to 
examine whether Rh-SAA could induce insulin 
resistance in adipocytes, the JNK, an important 
modulator was chosen for study. Thus, the effect of 
Rh-SAA on JNK activity in 3T3-L1 adipocytes and 
effects of JNK inhibitor intervention was studied to 
understand the possible mechanism of Rh-SAA-
induced insulin resistance in adipocytes. It might help 
in development of new treatment regimes for IR 
related disorders such as type-2 diabetes and 
metabolic syndrome. 
 
Materials and Methods 
Cells and main reagents  
The 3T3-L1 preadipocyte cell line was procured 
from Shanghai Cell Bank (Chinese Academy of 
Sciences, Shanghai, China). The Dulbecco's Modified 
Eagle's medium (DMEM) medium was purchased 
from Gibco, USA, and the 3H-2-DG was procured 
from Beyotime Biotechnology (Shanghai, China). The 
Rh-SAA (Peprotech, USA),ECL luminescence 
reagent (Santa Cruz, USA), Anti-JNK Rabbit mAb,  
p-JNK Rabbit mAb (Thr183/Tyr185), β-actin 
Rabbit mAb, Horseradish peroxidase-conjugated goat 
anti-mouse IgGandSP600125 were purchased from 
Cell Signaling Technology (USA).  
 
Experimental group assignment and cell culture  
In the preset study, experiment was divided into 
three groups (i) NC Group: Adipocytes without Rh-
SAA intervention; (ii) Rh-SAA Group: Adipocyte 
with 20 μg/mL Rh-SAA intervention; and (iii) JNK 
Inhibitor Group: the adipocytes pretreated with  
50 μmol/L JNK inhibitor SP600125 12 h before  
20 μg/mL Rh-SAA intervention. Glucose uptake  
and immunoblotting was performed after 48 h of 
incubation13. 
 
Detection of glucose transport rate by3H-2-DG 
Medium of adipocytes was removed and 
adipocytes were washed thrice with Krebs-Ringer-
Phosphate (KRP) buffer. The adipocytes were 
incubated with KRP buffer with or without 100 nmol/L 
insulin at 37°C for 30 min. Next 3H-2-DG was added 
to adjust the final concentration to 0.5 μCi/mL per 
well, and incubated at 37°C for 10 min. After the 
reaction was stopped by rapid washing thrice with 
pre-cooled PBS buffer, 1.0 mL of 0.1 mol/LNaOH 
was added and cells were incubated for 2 h4. Finally, 
NaOH was removed and 0.5 mL cell lysate was added 
into a scintillation vial, added with scintillation fluid 
and counted the number of disintegrations per minute 
(dpm) on a liquid scintillation counter. Meanwhile, 
the amount of total protein per well of the adipocytes 
was determined using the Kaumas brilliant blue micro 
protein assay. The number of disintegrations per 
minute per mg protein (dpm/mg protein) was used to 
suggest glucose transport in different experimental 
groups. In addition, another group was added with  
10 μmol/L cytochalasin B as the non-specific uptake 
rate of 3H-2-DG. This value was subtracted from  
all data as the glucose uptake value for each group  
of adipocytes. 
 
Western blotting and analysis 
The whole proteins from adipocytes were extracted 
by radioimmunoprecipitation assay (RIPA) buffer, 
and the concentrations were quantified using BCA 
protein assay kit. Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) 
(10% resolving gel) was conducted to separate the 
whole proteins (50 μg/lane)7. After the SDS-PAGE, 
the protein lanes were transferred from the gel onto 
polyvinylidene difluoride (PVDF) membranes at 90V. 
After 80 min of transferring process on PVDF 
membranes, 5% skimmed milk was used to block  
the membrane over an hour. Then JNK, p-JNK and  
β-actin primary antibodies (diluted by 1:1000) were 
used to incubate the membrane overnight at 4°C. 
Furthermore, 1X Tris-Buffered Saline, 0.1% Tween 
20 detergent (TBST) buffer was used for washing the 
membranes. The membranes were incubated in 
horseradish peroxidase-conjugated goat anti-mouse 
IgG secondary antibody for 1 h at room temperature 
(25°C). Finally, ECL reagents and film was used to 
exposure and detect the protein bands. The protein 




bands were analyzed by Gel Pro Analyzer software. 
The gray ratio of the p-JNK protein band to the JNK 
protein band was used as the relative expression of  
p-JNK, and β-actin was used as a reference. The 
relative expression of the target protein in NC group 
was set at 100%, and used as the standard. 
The study was approved and carried out as per 
guidelines of Ethics Committee, Drum Tower 
Hospital, affiliated to Nanjing University Medical 
School, Jiangsu province, China. 
 
Statistical analysis 
All the data were analyzed using SPSS21.0 
software (SPSS Inc., Chicago, IL, USA), and 
presented as the mean ± SEM. One-way analysis of 
variance (ANOVA) was used among multiple groups 
comparison followed by Student-Newman-Keuls post 
hoc test. The value of P <0.05 was considered as 
statistically significant. 
 
Results and Discussion 
Effects of JNK inhibitor on Rh-SAAmediated insulin 
resistance in 3T3-L1 adipocytes 
The glucose uptake ability of adipocytes treated 
with 20 μg/mL Rh-SAA for 48 h decreased by about 
26% compared with the NC group, and glucose 
uptake was increased by 15% in the JNK inhibitor 
group compared to Rh-SAA group (P<0.05). These 
results suggested that JNK inhibitor could restore the 
decrease of insulin sensitivity of adipocytes induced 
by Rh-SAA, and Rh-SAA could induce insulin 
resistance partly mediated by JNK as a consequence 
(Table 1). 
The data suggested that Rh-SAA induced insulin 
resistance was partly related to JNK signaling 
pathway. JNK inhibitor could partially restore Rh-
SAA induced insulin resistance, treated 3T3-L1 
adiposities with 20 μg/mL Rh-SAA for 48 h, and then 
detected the phosphorylation of JNK by Western 
blotting. Adochio et al.16 also found that reduced 
expression of p85α or p70 S6 kinase rescued 
adipocytes from IR induced by serine phosphorylation 
of insulin receptor substrate-1 and restored 
phosphatidylinositol-3-kinase activity and glucose 
uptake. In another study, inflammatory kinase c-jun 
N-terminal kinase (JNK) was found to respond to 
various cellular stress signals activated by cytokines, 
free fatty acids and hyperglycemia. Besides, JNK 
mediates both insulin resistance and ß-cell 
dysfunction, thus a potential target for type 2 diabetes 
therapy17.  
Many studies have shown that cell signaling 
pathway activated by insulin receptor cross-interacts 
with the signal transduction by inflammatory 
factors18. Inflammatory factors generated by non-
specific inflammation induce insulin resistance by 
inducing the phosphorylation of serine and threonine 
of insulin receptor substrate-1 (IRS-1) in insulin-
sensitive cells, impeding the tyrosine phosphorylation 
of IRS and blocking insulin signaling19. 
 
Effect of Rh-SAA on phosphorylation of JNK in 3T3-L1 
adipocytes 
The protein level of p-JNK was 100, 166 and 107% 
in NC group, Rh-SAA group and JNK inhibitor 
group, respectively. Results revealed that the 
phosphorylation of JNK increased by 66% in Rh-SAA 
group compared with NC group (P <0.01). 
Furthermore, there was significant difference between 
JNK inhibitor group and Rh-SAA group (P <0.01), 
however, the difference was not significant compared 
JNK Inhibitor group with NC group (P >0.05). The 
Rh-SAA increased the activity of JNK in adipocytes, 
and JNK inhibitor partially restored the cellular 
insulin resistance induced by Rh-SAA. Hence,  
Rh-SAA mediated insulin resistance is related to  
the activation of JNK pathway (Table 2). In another 
study, recombinant serum amyloid A (rSAA) 
enhanced the proliferation and inhibited 
differentiation in 3T3-L1 preadipocytes and also 
altered the insulin sensitivity in differentiated cells20.  
In this study, it was found that the phosphorylation 
level of JNK in Rh-SAA group was 66% higher than 
that in NC group. However, pretreated with JNK 
Table 1 — Effects of JNK inhibitor on Rh-SAAmediated insulin 
resistance in 3T3-L1 adipocytes (Glucose transport) 
Group Sample 
Glucose Transport Rate (%) 
Normal insulin stimulation 
NC 3 46.34±6.49 265.13±13.58 
Rh-SAA 3 41.97±5.82 196.63±13.99* 
JNK Inhibitor 3 39.28±7.94 237.16±18.87△ 
F value  0.822 14.50 
P value  0.484 0.005 
[Compared with NC group, *P <0.01; Compared with Rh-SAA 
group, △P <0.05] 
 
 
Table 2 — Effects of JNK inhibitor on Rh-SAA mediated insulin 
resistance in 3T3-L1 adipocytes (2-DG transport) 
Group Sample 
2-DG Transport Rate (%) 
Normal insulin stimulation 
NC 3 17.47±2.45 100.00±5.13 
Rh-SAA 3 15.84±2.19 74.20±5.30* 
JNK Inhibitor 3 14.82±3.00 89.49±7.12△ 
F value  0.822 14.50 
P value  0.484 0.005 




inhibitor followed by Rh-SAA, the phosphorylation of 
JNK decreased by 59% compared with Rh-SAA 
group. That is, JNK inhibitor essentially restored the 
increase of JNK phosphorylation induced by Rh-SAA 
(Table 3). It could be seen that the activation of JNK 
signaling pathway might be a key signaling molecule 
for Rh-SAA mediated insulin resistance in adipocytes. 
Therefore, the intervention of the activity of JNK is 
expected to be an effective method of treating insulin 
resistance related diseases. Yet in another study, JNK 
is an essential component of the pathway responsible 
for SAA-induced insulin resistance in 3T3-L1 
adipocytes. Such studies suggest that a selective 
interference with JNK activity may help in 
development of treatment for Type 2 diabetes and 
other insulin-resistant states21. 
Multiple studies have shown that increased JNK 
activity in adipose tissue of obese mice and obese 
people. In hereditary and diet-induced obese mice, the 
activity of JNK is significantly elevated in the liver, 
skeletal muscle and adipose tissue22. Compared with 
wild type obese mice, HFD JNK-KO obese mice 
showed significant reductions in both plasma glucose 
and insulin levels as well as serine phosphorylation 
level of IRS-1, but their tyrosine phosphorylation of 
IRS-1 and the sensitivity to insulin increased23. 
Genetically obese mice (ob/ob) with targeted 
mutations in JNK have also acquired similar results 
and the JNK deficient dietary and hereditary diabetic 
animal models have some improvement in insulin 
resistance in the environment6. In addition, negative 
regulation of insulin signaling by JNK was further 
confirmed by blocking the JNK pathway using 
adenovirus-mediated dominant-negative JNK or JNK 
inhibitory polypeptide and the obese diabetic animal 
models C57BL/KsJ-db/db mice treated with Ad-DN-
JNK exhibited low non-fasting blood glucose 
levels24,25. Besides, in Ad-DN-JNK treated mice,  
IRS-1 serine phosphorylation was significantly 
reduced and tyrosine phosphorylation was 
significantly increased in the liver compared with the 
control group, and Akt-serine 473 phosphorylation 
was decreased. In contrast, excessive expression of 
JNK in the liver of normal mice reduces insulin 
sensitivity. Taken together, blocking JNK pathway 
could attenuate insulin resistance and improve 
glucose tolerance in obese diabetic mice26,27.  
 
Conclusion 
This study showed that the JNK inhibitor could 
restore the decreased insulin sensitivity of adipocytes 
induced by Rh-SAA, and Rh-SAA could induce 
insulin resistance (IR) partly mediated by JNK. 
Furthermore, the Rh-SAA increased the activity of 
JNK in adipocytes, and JNK inhibitor partially 
restored the cellular IR induced by Rh-SAA. Thus, 
the activation of the JNK signaling pathway may be a 
key signaling molecule for Rh-SAA-mediated insulin 
resistance in adipocytes.  
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